Skip navigation
Agenda

Elevate Best Practices in Fair Market Value Calculations to Ensure Compliance

May 3-4, 2018
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE THURSDAY, MAY 3, 2018

7:30

Registration and Continental Breakfast

8:30

Chairman’s Welcome and Opening Remarks

Kevin Espinoza
Vice President, Healthcare Compliance Officer
BTG PLC

Key Considerations for FMV Frameworks

8:45

Harmonize FMV Programs and Processes Internally to Enhance Operations

Valerie Burkholder
Consultant, FMV and Physician Payment Reporting
Eli Lilly and Company (Retired)

9:30

Develop Effective Systems for Processing Exceptions

Kyla Garrison
Global Health Care Provider Interactions
W.L. Gore & Associates, Inc.

10:15

Networking and Refreshment Break

10:45

Understand Challenges in the Application of Bona Fide Service Fee Test and its Operational Implications

John Moose
Principal
Polaris, a QuintilesIMS Company

Samantha Sutherland
Engagement Manager
Polaris, a QuintilesIMS Company

11:30

Key Considerations of Managing a Fee-for-Service and Fair Market Value Framework

Sajid Saeed
Fair Market Value and Fee for Service Lead
GSK

12:15

Networking Luncheon

1:30

Analyze Challenges in Utilizing FMV Calculations in Rare Disease and Specialty Areas

Meghan Bagshaw
Director Global Medical Affairs Operations
SAGE Therapeutics

Richard Eschle
Executive Director, Corporate Ethics & Compliance
Eisai Inc.

2:15

Delve Into FMV and Stakeholder Relationships

Kevin Espinoza
Vice President, Healthcare Compliance Officer
BTG PLC

3:00

Networking and Refreshment Break

Explore Applications of FMV in Clinical Trials
and Enhance HCP Interactions

3:30

Analyze the Application of FMV in Clinical Trials

Masha Chestukhin
Associate Director, Compliance Officer R&D & IA and FMV
Sanofi-Genzyme

4:15

Enhance HCP Relationship Management Through Compliant Interactions

Heather Reavey
Senior Manager, HCP Consulting Management
Olympus Corporation of the Americas

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO FRIDAY, MAY 4, 2018

8:00

Continental Breakfast

8:00

Chairman’s Review of Day One

Kevin Espinoza
Vice President, Healthcare Compliance Officer
BTG PLC

Implement and Maintain
Effective Global FMV Practices

8:45

Build Effective Strategies and Methods for Global FMV Implementation

Davida Baker
Director, Transparency Reporting
AstraZeneca

Kyla Garrison
Global Health Care Provider Interactions
W.L. Gore & Associates, Inc.

9:30

Review Cross-Border Complexities in HCP Engagements

Julie DeLong, CFA
Managing Director, Transaction Advisory Services
Navigant

Melanie Fagan
Medical and Compliance Manager, Lead US External Expert Engagement HUB
GSK

10:15

Networking and Refreshment Break

Elevate Transparency and Compliance Through Strong Systems and Documentation

10:45

Explore Best Practices for Open Payments Reporting of HCP Spend

Speaker TBA

11:30

Assess FMV Compliance Monitoring and Risk Management Strategies

Richard Eschle
Executive Director, Corporate Ethics & Compliance
Eisai Inc.

12:15

Close of Conference

Agenda

Want more agenda details? Download the brochure.
Want more agenda details? Download the brochure.

DAY ONE THURSDAY, MAY 3, 2018

7:30

Registration and Continental Breakfast

8:30

Chairman’s Welcome and Opening Remarks

Kevin Espinoza
Vice President, Healthcare Compliance Officer
BTG PLC

Key Considerations for FMV Frameworks

8:45

Harmonize FMV Programs and Processes Internally to Enhance Operations

Valerie Burkholder
Consultant, FMV and Physician Payment Reporting
Eli Lilly and Company (Retired)

9:30

Develop Effective Systems for Processing Exceptions

Kyla Garrison
Global Health Care Provider Interactions
W.L. Gore & Associates, Inc.

10:15

Networking and Refreshment Break

10:45

Understand Challenges in the Application of Bona Fide Service Fee Test and its Operational Implications

John Moose
Principal
Polaris, a QuintilesIMS Company

Samantha Sutherland
Engagement Manager
Polaris, a QuintilesIMS Company

11:30

Key Considerations of Managing a Fee-for-Service and Fair Market Value Framework

Sajid Saeed
Fair Market Value and Fee for Service Lead
GSK

12:15

Networking Luncheon

1:30

Analyze Challenges in Utilizing FMV Calculations in Rare Disease and Specialty Areas

Meghan Bagshaw
Director Global Medical Affairs Operations
SAGE Therapeutics

Richard Eschle
Executive Director, Corporate Ethics & Compliance
Eisai Inc.

2:15

Delve Into FMV and Stakeholder Relationships

Kevin Espinoza
Vice President, Healthcare Compliance Officer
BTG PLC

3:00

Networking and Refreshment Break

Explore Applications of FMV in Clinical Trials
and Enhance HCP Interactions

3:30

Analyze the Application of FMV in Clinical Trials

Masha Chestukhin
Associate Director, Compliance Officer R&D & IA and FMV
Sanofi-Genzyme

4:15

Enhance HCP Relationship Management Through Compliant Interactions

Heather Reavey
Senior Manager, HCP Consulting Management
Olympus Corporation of the Americas

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO FRIDAY, MAY 4, 2018

8:00

Continental Breakfast

8:00

Chairman’s Review of Day One

Kevin Espinoza
Vice President, Healthcare Compliance Officer
BTG PLC

Implement and Maintain
Effective Global FMV Practices

8:45

Build Effective Strategies and Methods for Global FMV Implementation

Davida Baker
Director, Transparency Reporting
AstraZeneca

Kyla Garrison
Global Health Care Provider Interactions
W.L. Gore & Associates, Inc.

9:30

Review Cross-Border Complexities in HCP Engagements

Julie DeLong, CFA
Managing Director, Transaction Advisory Services
Navigant

Melanie Fagan
Medical and Compliance Manager, Lead US External Expert Engagement HUB
GSK

10:15

Networking and Refreshment Break

Elevate Transparency and Compliance Through Strong Systems and Documentation

10:45

Explore Best Practices for Open Payments Reporting of HCP Spend

Speaker TBA

11:30

Assess FMV Compliance Monitoring and Risk Management Strategies

Richard Eschle
Executive Director, Corporate Ethics & Compliance
Eisai Inc.

12:15

Close of Conference